SCHEMBL762553

SCHEMBL762553

CCCCNc1cc(OC)ccc1[N+](=O)[O-]

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.60
MAPT P10636 9/20 0.58
LMNA P02545 4/20 0.58
TDP1 Q9NUW8 3/20 0.55
ALPG P10696 1/20 0.55
HCAR3 P49019 2/20 0.53
POLB P06746 1/20 0.53
PKM P14618 1/20 0.53
SIRT5 Q9NXA8 1/20 0.53
KAT2B Q92831 1/20 0.52
ALDH1A1 P00352 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MAPK1 P28482 1/20 0.50
AKR1B10 O60218 1/20 0.50
AKR1B1 P15121 1/20 0.50
AKR1C4 P17516 1/20 0.50
AKR1C3 P42330 1/20 0.50
AKR1C2 P52895 1/20 0.50
AKR1C1 Q04828 1/20 0.50
HTR6 P50406 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21815032 0.89 MAPT (0.64) SMN1; SMN2MAPTLMNATDP1HCAR3
SCHEMBL739095 0.87 MAPT (0.64) SMN1; SMN2MAPTLMNATDP1ALPG
SCHEMBL2013684 0.87 SMN1; SMN2 (0.60) SMN1; SMN2MAPTLMNATDP1ALPG
SCHEMBL2220740 0.86 MAPT (0.59) SMN1; SMN2MAPTLMNATDP1ALPG
SCHEMBL10576590 0.86 LMNA (0.68) SMN1; SMN2MAPTLMNATDP1ALPG
SCHEMBL10580319 0.86 MAPT (0.58) SMN1; SMN2MAPTLMNATDP1ALPG
SCHEMBL29392855 0.86 KAT2B (0.59) SMN1; SMN2MAPTLMNATDP1ALPG
SCHEMBL111539 0.86 KAT2B (0.59) SMN1; SMN2MAPTLMNATDP1ALPG
SCHEMBL9760548 0.85 MAPT (0.63) SMN1; SMN2MAPTLMNATDP1ALPG
SCHEMBL16407600 0.85 MAPT (0.55) SMN1; SMN2MAPTLMNATDP1ALPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed